Why is everything biomedicine? Why is it Geng Tongxue (耿同学)?

A cultural shorthand for a realignment

China’s talent and capital are visibly clustering around biomedicine — and a new internet shorthand, Geng Tongxue (耿同学), has come to personify that shift. The nickname has been used online to describe a certain type of high‑achieving student or young professional who opts for medicine, life sciences or biotech research as the safest route to status and career security. Why is everyone suddenly choosing pipettes over pixels?

Policy, prestige and pandemic lessons

There are several forces pushing people toward the field. Beijing has repeatedly signalled biomedicine as a strategic industry — pandemic preparedness, public health infrastructure and ambitions for technological self‑reliance make the sector politically attractive. It has been reported that government funding, preferential hiring in state institutions and generous research grants have raised the perceived upside for students and universities. At the same time, the COVID‑19 era highlighted both the social importance and public prestige of biomedical work, nudging families and top scorers toward the field.

Market dynamics and social critique

Money is following the attention. Venture capital and incubators have ramped up biotech deals in China, and high schools and universities are funneling more applicants into biomedical tracks. But critics warn of a crowding effect: oversupply of graduates for narrow roles, inflated expectations, and a hollowing out of other essential disciplines such as engineering, education and basic sciences. It has been reported that some employers complain of a mismatch between graduates’ training and industry needs — more credentials, fewer job‑ready skills. Is the country building a resilient bioscience ecosystem, or simply recreating a bubble in a new guise?

Geopolitics, self‑reliance and uncertainty

International tensions add another layer. Reportedly, Western export controls on advanced research tools and heightened scrutiny of China‑bound collaborations have sharpened domestic urgency to cultivate indigenous capabilities. That geopolitical pressure both justifies and accelerates state and private investment — but it also raises stakes for students and founders who are betting their futures on a sector shaped by policy shifts and global competition. For observers and participants alike, the central question remains: will this concentration of talent and capital produce sustainable innovation, or will it amplify the next set of policy and market dislocations?